Uterine Sarcoma Morcellation, Impact on Survival

Lately, power morcellation during benign gynecologic surgery has come under scrutiny because of risk of abdominal dissemination of unsuspected malignant tissue. Although incidence of uterine sarcomas is low (0, 5 a 3, 3% /100.000 women every year) and the benefits of minimal invasive surgery versus laparotomy are widely accentuated, the morcellation of an undiagnosed cancer may be strongly adverse for the patient's prognosis. The current study pretends to illustrate the case of a morcellated low grade endometrial stromal sarcoma with much decreased overall survival than appreciated currently and present evidence published up to the date.